GlassScriptPhysician profile
Sunya N Ali
NPI 1568017689
$909.56
in general payments reported to CMS, 2019-2025
14 companies · $15.00 in 2025
The $15.00 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.12 · 2021: $171 · 2022: $335 · 2023: $327 · 2024: $14.77 · 2025: $15.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $186.10 | 2022-2023 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $139.51 | 2021-2022 | |
| Allergan, INC. | $136.12 | 2020-2022 | |
| Bausch & Lomb Americas INC. | $93.85 | 2022-2025 | Vyzulta, Miebo, Prolensa |
| Abbvie INC. | $64.73 | 2023-2024 | Alphagan P, Lumigan, Durysta |
| Biotissue Holdings INC. | $62.64 | 2022-2023 | |
| Sight Sciences, INC. | $47.04 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $43.52 | 2021-2023 | Eylea |
| Johnson & Johnson Surgical Vision, INC. | $42.07 | 2023 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Johnson & Johnson Vision Care, INC. | $33.43 | 2020 | |
| Thea Pharma INC. | $16.18 | 2023 | |
| Sun Pharmaceutical Industries INC. | $15.94 | 2023 | Cequa |
| Alcon Vision LLC | $14.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunya Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.